Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Labcorp Holdings (0JSY) Share Price & Analysis

0JSY Stock Chart & Stats

$360.60-$4.18(-1.15%)
At close: 4:30 PM GMT
$300$325$3503 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$359.68 - $371.81
52-Week Range
$245.87 - $371.81
Previous Close
$364.78
Volume
1
Average Volume (3M)
213
Market Cap
$29.31B
Enterprise Value
$31.67B
Total Cash (Recent Filing)
$261.80M
Total Debt (Recent Filing)
$6.78B
Price to Earnings (P/E)
29.5
Beta
0.70
Next Earnings
Feb 11, 2027 (Est.)
EPS Estimate
4.51
Next Dividend Ex-Date
Nov 24, 2026
Dividend Yield
0.80%

Bulls Say, Bears Say

Bulls Say

Broad-based Growth And Margin Expansion

Growth is broad enough to support durable operating improvement rather than relying on a single product or customer. Revenue expansion combined with higher margins indicates operating leverage and productivity benefits, strengthening the company’s ability to grow earnings and cash flow over the next several quarters.

Biopharma Laboratory Backlog

The large BLS backlog provides meaningful visibility into future revenue conversion and supports the durability of the drug-development services franchise. Strong book-to-bill and double-digit organic growth also indicate sustained demand from biopharma customers, while expanded laboratory capacity can support continued execution.

Specialty Diagnostics And Innovation

Faster specialty-testing growth can improve Labcorp’s mix and deepen physician relationships because specialty orders often generate additional core laboratory testing. FDA-cleared and approved offerings in oncology, neurology, and precision medicine broaden the company’s differentiated platform and support longer-term relevance.

Bears Say

PAMA Reimbursement Pressure

The proposed reimbursement reductions represent a structural pressure on the diagnostics business rather than a temporary fluctuation. Lower Medicare and Medicaid rates could compress revenue and margins across multiple years, requiring productivity savings, growth, and mix improvement to preserve the company’s earnings trajectory.

Meaningful Leverage

Although leverage has improved from 2024–2025, the debt load remains a meaningful fixed obligation relative to equity. This reduces balance-sheet flexibility and makes sustained earnings and cash generation important for continued deleveraging, acquisitions, capital returns, and resilience if operating conditions weaken.

Moderate Cash Conversion And Below-peak Margins

Labcorp generates substantial absolute cash, but cash conversion is not fully keeping pace with reported earnings, limiting internal funding efficiency. Profitability has recovered from 2023 yet remains below prior peaks, so additional execution is needed before the business can demonstrate fully restored margin durability.

Labcorp Holdings News

0JSY FAQ

What was Labcorp Holdings’s price range in the past 12 months?
Labcorp Holdings lowest share price was $245.87 and its highest was $371.81 in the past 12 months.
What is Labcorp Holdings’s market cap?
Labcorp Holdings’s market cap is $29.31B.
When is Labcorp Holdings’s upcoming earnings report date?
Labcorp Holdings’s next earnings report is estimated for Feb 11, 2027 (not yet confirmed), which is in 101 days.
How were Labcorp Holdings’s earnings last quarter?
Labcorp Holdings released its earnings results on Oct 28, 2026. The company reported $4.78 earnings per share for the quarter, beating the consensus estimate of $4.644 by $0.136.
Is Labcorp Holdings overvalued?
According to Wall Street analysts Labcorp Holdings’s price is currently Undervalued.
Does Labcorp Holdings pay dividends?
Labcorp Holdings pays a Quarterly dividend of $0.72 which represents an annual dividend yield of 0.8%. See more information on Labcorp Holdings dividends here
What is Labcorp Holdings’s EPS estimate?
Labcorp Holdings’s EPS estimate is 4.51.
How many shares outstanding does Labcorp Holdings have?
Labcorp Holdings has 81,100,000 shares outstanding.
What happened to Labcorp Holdings’s price movement after its last earnings report?
Labcorp Holdings reported an EPS of $4.78 in its last earnings report, beating expectations of $4.644. Following the earnings report the stock price went up 10.471%.
Which hedge fund is a major shareholder of Labcorp Holdings?
Hedge funds hold Labcorp Holdings shares: the largest hedge-fund position in Labcorp Holdings is 1,763,763,349 shares, and hedge funds decreased their holdings by 104.1K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology